PAR 730 (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)
Pill with imprint PAR 730 is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Par Pharmaceutical, Inc..
Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PAR 730
Aspirin and Extended-Release Dipyridamole
- Imprint
- PAR 730
- Strength
- 25 mg / 200 mg
- Color
- Red & White
- Size
- 24.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Platelet aggregation inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 49884-0007
- Inactive Ingredients
-
lactose anhydrous, alginic acid, corn starch, stearic acid, povidone, triacetin, magnesium silicate, tartaric acid, acacia, gelatin, sodium lauryl sulfate, titanium dioxide, FD&C Red No. 40, FD&C Yellow No. 6, potassium hydroxide, xanthan gum, shellac, hypromelloses, ferric oxide red, ferric oxide yellow, water, ethylcelluloses, silicon dioxide, ferrosoferric oxide
Note: Inactive ingredients may vary.
More about aspirin / dipyridamole
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 16 Reviews
- Drug class: platelet aggregation inhibitors
Consumer resources
Other brands: Aggrenox
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
